T. Rowe Price Associates
RXO icon

T. Rowe Price Associates’s RXO RXO Stock Holding History

T. Rowe Price Associates’s Portfolio RXO Stock Details RXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.83M Buy
193,586
+30,491
+19% +$447K ﹤0.01% 1677
2025
Q4 		$2.06M Buy
163,095
+20,893
+15% +$308K ﹤0.01% 1737
2025
Q3 		$2.19M Buy
142,202
+9,575
+7% +$154K ﹤0.01% 1700
2025
Q2 		$2.08M Buy
132,627
+15,791
+14% +$239K ﹤0.01% 1617
2025
Q1 		$2.23M Buy
116,836
+11,070
+10% +$242K ﹤0.01% 1555
2024
Q4 		$2.52M Buy
105,766
+17,424
+20% +$486K ﹤0.01% 1545
2024
Q3 		$2.47M Buy
88,342
+7,189
+9% +$203K ﹤0.01% 1542
2024
Q2 		$2.12M Buy
81,153
+5,351
+7% +$111K ﹤0.01% 1527
2024
Q1 		$1.66M Buy
75,802
+1,663
+2% +$35.6K ﹤0.01% 1667
2023
Q4 		$1.73M Sell
74,139
-562,930
-88% -$11.3M ﹤0.01% 1613
2023
Q3 		$12.6M Sell
637,069
-31,058
-5% -$612K ﹤0.01% 1023
2023
Q2 		$15.1M Buy
668,127
+156,871
+31% +$3.16M ﹤0.01% 1008
2023
Q1 		$10M Buy
511,256
+1,115
+0.2% +$21.4K ﹤0.01% 1052
2022
Q4 		$8.78M Buy
+510,141
New +$9.05M ﹤0.01% 1076

Other funds holding RXO

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates's RXO Position: Q1 2026 in Review

T. Rowe Price Associates increased its RXO (RXO) stake by 19% in Q1 2026, buying an estimated $447K and bringing the position to 193,586 shares worth $2.83M. The position accounts for ﹤0.01% of the portfolio, ranked #1677.

T. Rowe Price Associates first reported a position in RXO in Q4 2022 and has held it in 14 quarters since. The position peaked at $15.1M in Q2 2023. 275 funds tracked by Wall St. Rank hold RXO as of Q1 2026.

  • T. Rowe Price Associates held 193,586 shares of RXO worth $2.83M as of Q1 2026.
  • T. Rowe Price Associates bought 30,491 RXO shares in Q1 2026, an estimated $447K.
  • RXO made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1677 holding.
  • T. Rowe Price Associates first reported a position in RXO in Q4 2022 and has held it in 14 quarters since.
  • T. Rowe Price Associates's RXO position peaked at $15.1M in Q2 2023.
  • 275 funds tracked by Wall St. Rank held RXO as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.